Jonathan K. Watts

6.1k total citations · 1 hit paper
80 papers, 4.2k citations indexed

About

Jonathan K. Watts is a scholar working on Molecular Biology, Organic Chemistry and Pathology and Forensic Medicine. According to data from OpenAlex, Jonathan K. Watts has authored 80 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Molecular Biology, 7 papers in Organic Chemistry and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Jonathan K. Watts's work include Advanced biosensing and bioanalysis techniques (35 papers), RNA Interference and Gene Delivery (32 papers) and DNA and Nucleic Acid Chemistry (20 papers). Jonathan K. Watts is often cited by papers focused on Advanced biosensing and bioanalysis techniques (35 papers), RNA Interference and Gene Delivery (32 papers) and DNA and Nucleic Acid Chemistry (20 papers). Jonathan K. Watts collaborates with scholars based in United States, Canada and United Kingdom. Jonathan K. Watts's co-authors include Anastasia Khvorova, Masad J. Damha, David R. Corey, Glen F. Deleavey, Feng Wang, Ruth N. Zadoks, Vivek Sharma, Jae‐Yeol Joo, Carlos Martinez and Katie Schaukowitch and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nucleic Acids Research.

In The Last Decade

Jonathan K. Watts

78 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The chemical evolution of oligonucleotide therapies of clinical utility

2017 865 citations Anastasia Khvorova, Jonathan K. Watts profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jonathan K. Watts United States	34	3.5k	585	326	221	184	80	4.2k
John J. Correia United States	33	2.6k 0.8×	354 0.6×	328 1.0×	183 0.8×	162 0.9×	99	3.9k
Sandra B. Gabelli United States	34	3.6k 1.1×	253 0.4×	255 0.8×	178 0.8×	313 1.7×	100	5.4k
O. Gileadi United Kingdom	44	4.3k 1.2×	333 0.6×	568 1.7×	158 0.7×	126 0.7×	108	5.5k
Guofeng Zhang United States	35	3.0k 0.9×	403 0.7×	1.0k 3.2×	275 1.2×	182 1.0×	106	4.2k
E.D. Lowe United Kingdom	33	2.8k 0.8×	198 0.3×	253 0.8×	157 0.7×	222 1.2×	66	4.2k
Sander R. Piersma Netherlands	40	2.8k 0.8×	852 1.5×	170 0.5×	270 1.2×	52 0.3×	137	4.7k
Oded Kleifeld Israel	31	2.6k 0.8×	1.0k 1.7×	260 0.8×	121 0.5×	185 1.0×	79	4.3k
Jiahai Shi Hong Kong	27	2.0k 0.6×	562 1.0×	197 0.6×	284 1.3×	84 0.5×	78	2.9k
Francisco N. Barrera United States	29	2.2k 0.6×	457 0.8×	101 0.3×	382 1.7×	129 0.7×	80	2.9k
Gerald M. Wilson United States	40	4.0k 1.1×	993 1.7×	185 0.6×	89 0.4×	111 0.6×	89	5.3k

Countries citing papers authored by Jonathan K. Watts

Since Specialization

Citations

This map shows the geographic impact of Jonathan K. Watts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan K. Watts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan K. Watts more than expected).

Fields of papers citing papers by Jonathan K. Watts

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan K. Watts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan K. Watts. The network helps show where Jonathan K. Watts may publish in the future.

Co-authorship network of co-authors of Jonathan K. Watts

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan K. Watts. A scholar is included among the top collaborators of Jonathan K. Watts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan K. Watts. Jonathan K. Watts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Oikemus, Sarah, Kai Hu, Masahiro Shin, et al.. (2025). Identifying optimal conditions for precise knock-in of exogenous DNA into the zebrafish genome. Development. 152(12). 1 indexed citations

Belgrad, Jillian, Erin M. McConnell, Simon Léonard, et al.. (2025). The N=1 Collaborative: advancing customized nucleic acid therapies through collaboration and data sharing. Nucleic Acids Research. 53(8). 3 indexed citations

Myint, Wazo, Vanivilasini Balachandran, Ala M. Shaqra, et al.. (2025). Next generation APOBEC3 inhibitors: optimally designed for potency and nuclease stability. Nucleic Acids Research. 53(6).

Fakih, Hassan H., Karen Kelly, Gitali Devi, et al.. (2024). Quantifying the activity profile of ASO and siRNA conjugates in glioblastoma xenograft tumors in vivo. Nucleic Acids Research. 52(9). 4799–4817. 6 indexed citations

Shahzad, Uswa, Christopher Li, Michael J. Johnston, et al.. (2024). CASCADES, a novel SOX2 super‐enhancer‐associated long noncoding RNA, regulates cancer stem cell specification and differentiation in glioblastoma. Molecular Oncology. 19(3). 764–784. 5 indexed citations

Ferguson, Chantal, Bruno M.D.C. Godinho, Dimas Echeverria, et al.. (2024). A combinatorial approach for achieving CNS-selective RNAi. Nucleic Acids Research. 52(9). 5273–5284. 3 indexed citations

Shah, Sneha, et al.. (2023). Antisense oligonucleotide rescue of CGG expansion–dependent FMR1 mis-splicing in fragile X syndrome restores FMRP. Proceedings of the National Academy of Sciences. 120(27). e2302534120–e2302534120. 26 indexed citations

Kelly, Karen, Jonathan Lee, Dimas Echeverria, et al.. (2023). Self-delivering, chemically modified CRISPR RNAs for AAV co-delivery and genome editing in vivo. Nucleic Acids Research. 52(2). 977–997. 10 indexed citations

Chen, Zexiang, Suet‐Yan Kwan, Aamir Mir, et al.. (2023). A Fluorescent Reporter Mouse for In Vivo Assessment of Genome Editing with Diverse Cas Nucleases and Prime Editors. The CRISPR Journal. 6(6). 570–582. 3 indexed citations

10.

Chen, Zexiang, Karen Kelly, Xiaolong Dong, et al.. (2023). In Vivo Prime Editing by Lipid Nanoparticle Co-Delivery of Chemically Modified pegRNA and Prime Editor mRNA. PubMed. 2(6). 490–502. 15 indexed citations

11.

Wang, Feng, Minggang Fang, Jacquelyn Sousa, et al.. (2022). G-rich motifs within phosphorothioate-based antisense oligonucleotides (ASOs) drive activation of FXN expression through indirect effects. Nucleic Acids Research. 50(22). 12657–12673. 4 indexed citations

12.

Liang, Shun‐Qing, Pengpeng Liu, Jordan L. Smith, et al.. (2022). Genome-wide detection of CRISPR editing in vivo using GUIDE-tag. Nature Communications. 13(1). 437–437. 34 indexed citations

13.

Aartsma‐Rus, Annemieke, Alejandro Garanto, Willeke van Roon‐Mom, et al.. (2022). Consensus Guidelines for the Design and In Vitro Preclinical Efficacy Testing N-of-1 Exon Skipping Antisense Oligonucleotides. Nucleic Acid Therapeutics. 33(1). 17–25. 35 indexed citations

14.

Krishnan, Gopinath, Denitza Raitcheva, Daniel A. Bartlett, et al.. (2022). Poly(GR) and poly(GA) in cerebrospinal fluid as potential biomarkers for C9ORF72-ALS/FTD. Nature Communications. 13(1). 2799–2799. 31 indexed citations

15.

Liu, Pengpeng, Ogooluwa Ojelabi, Xin D. Gao, et al.. (2022). Adenine Base Editing In Vivo with a Single Adeno-Associated Virus Vector. PubMed. 1(3). 285–299. 43 indexed citations

16.

Ghanta, Krishna S., Zexiang Chen, Aamir Mir, et al.. (2021). 5′-Modifications improve potency and efficacy of DNA donors for precision genome editing. eLife. 10. 38 indexed citations

17.

Krishnamurthy, Pranathi M., et al.. (2021). Quantification of Antisense Oligonucleotides by Splint Ligation and Quantitative Polymerase Chain Reaction. Nucleic Acid Therapeutics. 32(1). 66–73. 21 indexed citations

18.

Osborn, Maire F., Andrew H. Coles, Diane Golebiowski, et al.. (2018). Efficient Gene Silencing in Brain Tumors with Hydrophobically Modified siRNAs. Molecular Cancer Therapeutics. 17(6). 1251–1258. 17 indexed citations

19.

Mir, Aamir, Julia F. Alterman, Matthew Hassler, et al.. (2018). Heavily and fully modified RNAs guide efficient SpyCas9-mediated genome editing. Nature Communications. 9(1). 2641–2641. 86 indexed citations

20.

Saini, Neeraj, et al.. (2017). Targeting the Mechanism of c-Mpl Exon-Inclusion through Antisense Oligonucleotides Yields a Dominant Negative Isoform. Blood. 130. 383–383. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact